Sunmax Biotechnology Co., Ltd.

TPEX:4728 Stock Report

Market Cap: NT$17.0b

Sunmax Biotechnology Past Earnings Performance

Past criteria checks 5/6

Sunmax Biotechnology has been growing earnings at an average annual rate of 38.1%, while the Biotechs industry saw earnings growing at 15.8% annually. Revenues have been growing at an average rate of 26.2% per year. Sunmax Biotechnology's return on equity is 41.9%, and it has net margins of 39.1%.

Key information

38.1%

Earnings growth rate

38.1%

EPS growth rate

Biotechs Industry Growth12.2%
Revenue growth rate26.2%
Return on equity41.9%
Net Margin39.1%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Investors Who Bought Sunmax Biotechnology (GTSM:4728) Shares Three Years Ago Are Now Up 166%

Feb 28
Investors Who Bought Sunmax Biotechnology (GTSM:4728) Shares Three Years Ago Are Now Up 166%

Is Sunmax Biotechnology Co., Ltd. (GTSM:4728) The Right Choice For A Smart Dividend Investor?

Feb 02
Is Sunmax Biotechnology Co., Ltd. (GTSM:4728) The Right Choice For A Smart Dividend Investor?

Sunmax Biotechnology Co., Ltd.'s (GTSM:4728) Stock Is Going Strong: Is the Market Following Fundamentals?

Dec 20
Sunmax Biotechnology Co., Ltd.'s (GTSM:4728) Stock Is Going Strong: Is the Market Following Fundamentals?

Is Sunmax Biotechnology's (GTSM:4728) Share Price Gain Of 152% Well Earned?

Nov 24
Is Sunmax Biotechnology's (GTSM:4728) Share Price Gain Of 152% Well Earned?

Revenue & Expenses Breakdown

How Sunmax Biotechnology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TPEX:4728 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 241,72467448632
31 Dec 231,68962648129
30 Sep 231,67458249628
30 Jun 231,56453547423
31 Mar 231,46852943720
31 Dec 221,40053440718
30 Sep 221,29250636118
30 Jun 221,18141038920
31 Mar 221,09331642824
31 Dec 211,03624650225
30 Sep 211,05025152121
30 Jun 2199122849217
31 Mar 2195224545117
31 Dec 2085623835118
30 Sep 2071412232817
30 Jun 2071116230521
31 Mar 2067013430921
31 Dec 1959410031723
30 Sep 1953914526625
30 Jun 194279922823
31 Mar 193478218424
31 Dec 183047515820
30 Sep 182595014016
30 Jun 182294013116
31 Mar 182002812312
31 Dec 171901711212
30 Sep 171892410014
30 Jun 17188248713
31 Mar 1716427717
31 Dec 1615627720
30 Sep 16120-318119
30 Jun 16112-458922
31 Mar 16114-409420
31 Dec 15112-449421
30 Sep 15151-179330
30 Jun 1515108628
31 Mar 15165137926
31 Dec 14184207822
30 Sep 14177257710
30 Jun 1419328799
31 Mar 1421241819
31 Dec 13213488211
30 Sep 13227518214

Quality Earnings: 4728 has high quality earnings.

Growing Profit Margin: 4728's current net profit margins (39.1%) are higher than last year (36%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 4728's earnings have grown significantly by 38.1% per year over the past 5 years.

Accelerating Growth: 4728's earnings growth over the past year (27.4%) is below its 5-year average (38.1% per year).

Earnings vs Industry: 4728 earnings growth over the past year (27.4%) exceeded the Biotechs industry 1.7%.


Return on Equity

High ROE: 4728's Return on Equity (41.9%) is considered outstanding.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.